Sihuan Pharmaceutical Holdings Group Ltd. (HKG: 0460)

Sihuan Pharmaceutical Holdings Group Statistics

Total Valuation

Sihuan Pharmaceutical Holdings Group has a market cap or net worth of HKD 6.90 billion. The enterprise value is 3.60 billion.

Market Cap	6.90B
Enterprise Value	3.60B

Important Dates

The next estimated earnings date is Friday, November 29, 2024.

Earnings Date	Nov 29, 2024
Ex-Dividend Date	Sep 27, 2024

Share Statistics

Sihuan Pharmaceutical Holdings Group has 9.32 billion shares outstanding. The number of shares has decreased by -0.48% in one year.

Shares Outstanding	9.32B
Shares Change (YoY)	-0.48%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	7.61%
Owned by Institutions (%)	4.73%
Float	3.99B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.64
PB Ratio	1.45
P/FCF Ratio	59.58
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 265.27, with an EV/FCF ratio of 31.07.

EV / Earnings	-88.56
EV / Sales	1.91
EV / EBITDA	265.27
EV / EBIT	n/a
EV / FCF	31.07

Financial Position

The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.22.

Current Ratio	1.64
Quick Ratio	1.38
Debt / Equity	0.22
Debt / EBITDA	68.50
Debt / FCF	10.44
Interest Coverage	-0.73

Financial Efficiency

Return on equity (ROE) is -4.00% and return on invested capital (ROIC) is -1.92%.

Return on Equity (ROE)	-4.00%
Return on Assets (ROA)	-1.05%
Return on Capital (ROIC)	-1.92%
Revenue Per Employee	711,948
Profits Per Employee	-15,337
Employee Count	2,872
Asset Turnover	0.15
Inventory Turnover	1.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.31% in the last 52 weeks. The beta is 0.60, so Sihuan Pharmaceutical Holdings Group's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	+21.31%
50-Day Moving Average	0.57
200-Day Moving Average	0.57
Relative Strength Index (RSI)	60.92
Average Volume (20 Days)	35,979,967

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sihuan Pharmaceutical Holdings Group had revenue of HKD 1.89 billion and -40.61 million in losses. Loss per share was -0.00.

Revenue	1.89B
Gross Profit	1.24B
Operating Income	-211.03M
Pretax Income	-158.40M
Net Income	-40.61M
EBITDA	-15.99M
EBIT	-211.03M
Loss Per Share	-0.00

Balance Sheet

The company has 5.23 billion in cash and 1.21 billion in debt, giving a net cash position of 4.02 billion or 0.43 per share.

Cash & Cash Equivalents	5.23B
Total Debt	1.21B
Net Cash	4.02B
Net Cash Per Share	0.43
Equity (Book Value)	5.47B
Book Value Per Share	0.51
Working Capital	2.82B

Cash Flow

In the last 12 months, operating cash flow was 223.10 million and capital expenditures -107.35 million, giving a free cash flow of 115.75 million.

Operating Cash Flow	223.10M
Capital Expenditures	-107.35M
Free Cash Flow	115.75M
FCF Per Share	0.01

Margins

Gross margin is 65.91%, with operating and profit margins of -11.19% and -2.15%.

Gross Margin	65.91%
Operating Margin	-11.19%
Pretax Margin	-8.40%
Profit Margin	-2.15%
EBITDA Margin	-0.85%
EBIT Margin	-11.19%
FCF Margin	6.14%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 5.68%.

Dividend Per Share	0.04
Dividend Yield	5.68%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.48%
Shareholder Yield	6.16%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on June 5, 2014. It was a forward split with a ratio of 2.

Last Split Date	Jun 5, 2014
Split Type	Forward
Split Ratio	2

Scores

Sihuan Pharmaceutical Holdings Group has an Altman Z-Score of 0.97. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.97
Piotroski F-Score	n/a